News regarding Oslo Cancer Cluster`s R&D Network Member Meetings

Illustration: Oslo Cancer Society

Raising Prostate Cancer Awareness

This week on Monday, Prostate Cancer Day, the Norwegian Cancer Society initiated their Blue-Ribbon Campaign to raise prostate cancer awareness. In line with the campaign, Oslo Cancer Cluster gives you the chance to update yourselves on prostate cancer research Thursday the 30th of November.

 

The Blue-Ribbon campaign is initially a month’s focus on prostate cancer, one of the deadliest forms of cancers we know. On average, every day three people die of prostate cancer in Norway alone. Over the length of a year, that number climbs above 5000 and they are all exclusively male.

For 20 years the Pink-Ribbon Campaign has been synonymous with awareness of breast cancer, a form of cancer that almost exclusively affect women. The movement was a success and brought a lot of attention and money for breast cancer research. Now, the attention turns to men and prostate cancer.

Research Needed
— I think we will receive a lot of attention with this campaign. The disease affects so many and is under communicated. Men often keep this type of information to themselves. And importantly, we need more research on the subject, says Anne Lyse Ryel, Secretary General at the Norwegian Cancer Society.

First and foremost, the campaign aims to lift prostate cancer into the limelight. Subsequently lifting taboos and increasing awareness among men and the population at large. Next in line is money for research. It is severely needed because reaching 2030, estimates predict an 40 percent increase on the frequency of prostate cancer.

An Update on Prostate Cancer
However, research is very much ongoing. And, if you are wondering what the most current research on prostate cancer entails? Visit Oslo Cancer Cluster’s R&D Network Meeting that Thursday the 30th of November focuses on exactly prostate cancer research. It can serve as a very informative conclusion to a month of prostate cancer awareness. Listen to prominent experts explaining current research and where prostate cancer research is heading in the future.

Read more about our Prostate Cancer meeting.

Great interest in R&D Precision Cancer Medicine meeting

Over 50 people turned up for our R&D Network meeting on Precision Cancer Medicin at Stavanger University Hospital yesterday. The meeting was a collaboration beetween Oslo Cancer Cluster and Stavanger University Hospital(SUS) and was hosted by SUS.

The speaker list included Jon Arne Søreide from the Gastrointestinal Surgical Research Group, Bjørnar Gilje from the Reseach Group for Oncology and Medical Physics and Emiel Janssen from the research group at the Department of Pathology.

We were also fortunate to have Åslaug Helland from Oslo University Hospital (OUS) with us to give us some clinical perspectives. Helland is the group leader for the Research Group for Translation Studies on Solid Tumours. More info on Hellands group here

Representing the biotech side, we had Kjetil Hestdal from PhotoCure showing examples of the opportunities photodynamic technology give patients with bladder cancer.

Aslaug Aamodt Muggerud from MSD talked about biomarkers and how precision medicine is different from “traditional treatment”.

Great Kick-off for Oslo Cancer Cluster Innovation Park

More than 170 people kicked-off the Oslo Cancer Cluster Innovation Parkat the annual Oslo Cancer Cluster Summer Meeting. The Innovation park opens in less than a year, and for the first time participants from the cluster could come in side the Park.

 

 

Program

–15:00: Registration & coffee

15:00– 15:20: “Welcome – update on main projects”
– Ketil Widerberg, General Manager of Oslo Cancer Cluster

15:20–15:40: “The Radium Hospital Innovation Campus”
– Jan Vincent Johannessen, CEO Radium Hospital Foundation

15:40–16:00: “Ullern High School – Spring 2015”
– Esther Eriksen, Ullern High School

16:00–16:20: “Oslo Cancer Cluster Innovation Park”
– Jónas Einarsson, CEO of The Radium Hospital Research Foundation, founder of the Innovation Park

16:40–17:00: Refreshments

17:00–18:00: “New Kids on the Block” – presentations from new members;
• Teva Scandinavia, Asker
• Smartfish, Oslo
• Pharmalink, Stockholm
• NorChip, Hurum
• Oncoimmunity, Oslo
• SFF – Centre for Cancer Biomarkers, Bergen

18:00: Summer networking with exclusive group tours “inside” the Oslo Cancer Cluster Innovation Park guided by Skanska

 

 

The Radium Hospital Foundation support the R&D Network Meetings 2014

The Radium Hospital Foundation (Radiumhospitalets Legater) will support the Oslo Cancer Clusters R&D Network Meetings 2014, and collaborate closely with the cluster on developing these meetings.

Oslo Cancer Clusters R&D Network Meetings are the backbone of the clusters strategic goal to stimulate collaborations and partnership by further develop strong national and international networks.

Important for partnering and innovation
The R&D Network Meetings target the members and collaborators of the cluster and is usually held five to six times annually. Each R&D Network Meeting is focused on a specific oncology theme, featuring speakers and angles from basic research to pharma, encouraging interdiciplinary and multi-diciplinary comptence development and partnering.

“The R&D Network Meetings contribute to important networking for the researchers at the Radium Hospital. In addition it gives the participants the opportunity to keep up to date in the ever changing field of cancer research,” says Karl-Erik Giercksky, Clinical Advisor at the Radium Hospital Foundation.

Ketil Widerberg, General Manager of the Oslo Cancer Cluster is very grateful for the support: “The contribution from the Radium Hospital Foundation to our R&D Network Meetings is very important and will contribute to the importance of connecting the members of the cluster further. This is vital to drive and stimulate oncology innovations for the benefit of the cancer patients.”

The Radium Hospital Foundation
The Radium Hospital Foundation is built from gifts and donations given from people, organisations and large companies alike. These contributions enable The Radium Hospital to maintain their place as a world leading Comprehensive Cancer Center by supporting cancer research and excellent patient care.

Find more information on the Radium Hospital Foundation here.

 

R&D Network Meetings 2014

March 5th: Urologic Cancer

April 23rd: Personalised Medicine Workshop

August 20th: R&D Summer Meeting
Featuring presentations of the new members; New Kids on the Block

October 22nd: Conjugated antibodies

December 10th: Christmas R&D Network Meeting